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Interactions of the ligand/receptor pair LFA-1(CD11a/ 
CD18) and ICAM-1(CD54) initiate and control the cell-cell 
interactions ofleukocytes and interactions ofleukocytes with 
parenchymal cells in all phases of the immune response. In-
duction of the intercellular adhesion molecule 1 (ICAM-1) 
on the surface of epidermal keratinocytes has been proposed 
as an important regulator of contact-dependent aspects of 
cutaneous inflammation. Ultraviolet radiation (UVR) also 
modifies cutaneous inflammation, producing both up- and 
down-regulation of contact hypersensitivity. We have found 
that UVR has a biphasic effect on the induction of keratino-
cyte CD54. Using immunofluorescence and FACS tech-
niques to quantitate cell-surface CD54 staining, we have 
shown that UVR (100 mJ/cm2 of UVB) significantly (p 
<0.01) inhibits keratinocyte CD54 induction by gamma in-
terferon 24 h after irradiation. However, at 48, 72, and 96 h 
after UVR (10 to 100 mJ/cm2), CD54 expression is signifi-
cantly induced (p < 0.01 top< 0.001) to levels even greater 
T he complex effects of ultraviolet radiation (UVR) on contact hypersensitivity have been extensively stud-ied. Epidermal Langerhans cells surface markers are depleted by local UVR (1], and the density of these cells following UVR determines whether contact hy-
persensitivity (CHS) or unresponsiveness follows hapten presenta-
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Abbreviations: 
ADCC: antibody-dependent cellular cytotoxicity 
APC: antigen-presenting cell 
BSA: bovine serum albumin 
CHS: contact hypersensitivity 
CTL: cytotoxic T lymphocytes 
EDTA: ethylenediamine tetraacetic acid 
FACS: fluorescence-activated cell sorter 
FCS: fetal calf serum 
than are induced by gamma interferon (20 U /rnl). In add.i\ 
tion, at 48, 72, or 96 h following UVR (30-100 rnJ/cm2) 
the gamma-interferon- induced CD 54 expression on humar\ 
keratinocytes is also strongly (p < 0.05 to p < 0.001) et),1 hanced. In this cell-culture system, gamma interferon an.~ 
TNF-a are both strong CD54 inducers and are synergistic 
but GM-CSF, TFG-/3, and IL- l have no direct CD54-induc~ 
ing effects. 
Thus the effects ofUVR on CD54 induction: are biphasic 
producing inhibition at 24 hand induction at 48, 72, and 9& 
h. This effect on CD 54 may contribute to the biphasic effect~ 
ofUVR on delayed hypersensitivity in vivo. The early inhi, 
bition ofiCAM-1 by UVR may also contribute to the thera, 
peutic effects of UVR. We also speculate that the late indue, 
tion ofiCAM-1 by UVR might be an important step in th~ 
induction of photosensitive diseases such as lupus erythema, 
tosus.J Invest Dermatol95:132-138, 1990 
tion on the skin [2). In addition, very-high-dose UVR produc~ 
systemic abnormalities in antigen-presenting- cell (APe) function, 
(3- 4]. Both high- (5] and low-dose [ 6] UVR have also been sho'Wll, 
to generate suppressor cells, which can inhibit CHS and which ar~ 
associated with the development ofUV-induced skin tumor (7]. in, 
some systems, local UVR depletes normal APC and promotes th~ 
GM-CSF: granulocyte macrophage- colony-stimulating factor 
gp 150,95: glycoprotein 150,95 (CD11cCD18) 
IFN-y: interferon gamma or r-IFN-y for recombinant IFN-g 
IL-1: interleukin 1 
ICAM-1: intercellular adhesion molecule 1 (CD54) 
LAK: lymphokine-activated killing 
LFA-1: leukocyte function antigen 1 (CD11aCD18) 
MAC-1: (CD11bCD18) 
NK: natural killing 
NLE: neonatal lupus erythematosus 
PPD: paraphenylenediamine 
SCLE: subacute cutaneous lupus erythematosus 
SSA/Ro: Sjogrens-associated antigen A, also Ro antigen 
SSB/La: Sjogrens-associated antigen B, also La antigen 
TGF-P: transforming growth factor beta 1 
TNF-a: tumor necrosis factor alpha 
UV: ultraviolet 
UVR: ultraviolet radiation 
0022- 202X/90 f$03.50 Copyright © 1990 by The Society for Investigative Dermatology, Inc. 
132 
VOL. 95, NO. 2 AUGUST 1990 
migration of a UV-resistant APC to regional and central lymphatic 
tissue and the subsequent generation of suppressor cells (8] . 
Because UVR has been so extensively studied as an immunosup-
pressive agent, it was quite unexpected to discover a recovery of 
CHS following local UVR, and even a rebound to higher levels 
than before radiation (9]. In some experimental protocols, prior 
exposure to UVR enhances the elicitation phase of CHS (10]. Coo-
per and his colleagues have shown that following UVR a popula-
tion of antigen-presenting melanophages appears in human epi-
dennis [ 11], and these cells can act as potent APC, enhancing 
epidermal alloantigen presentation (9]. Little is known regarding 
the messages that induce this ingress of APC into the epidermis 
following UVR, or whether UVR may induce other factors or cells 
·that enhance the immunologic reactivity of the epidermis follow-
ing irradiation. 
It is now recognized that many of the cell-cell interactions among 
leukocytes and the interactions between leukocytes and the extra-
cellular matrix are mediated by proteins of the integrin superfamily 
wd their ligands (12]. The beta-2 integrin subfamily is composed of 
the heterodimers LFA-1 (CD11aCD18), Mac-1 (CD11bCD18), 
and gp 150,95 (CD11cCD18), which initiate or enhance cell-cell 
interactions [13] among leukocytes .. LFA-1 is present on all leuko-
cytes [14-15] and binds to the ligand ICAM-1 (CD54) [1 6-18], 
which is variably present on leukocytes and parenchymal cells [19]. 
The interaction ofLFA-1 and ICAM-1 are necessary for most con-
tact-dependent components of the immune response, including in-
teractions of APC with T cells and B cells (20,21], and interaction of 
immunologic effectors with targets (22-24] to induce immuno-
logic cytotoxicity. 
Modulation of ICAM-1 on the surface of parenchymal cells is 
believed to be an important variable in the control of migration of 
leukocytes into tissue and in the induction of specific immunologic 
reactions [25]. ICAM-1 is present in low levels on the surface of 
epidermal keratinocytes, but is induced by IFN-y and also by 
TNF-a (26] . This ligand induction promotes leukocyte attachment 
to keratinocytes (26], and is probably crucial in cytotoxic damage to 
keratinocytes (22] . 
Because ICAM-1 is essential to so many aspects of the immune 
response, we questioned whether the effects of UVR on cutaneous 
immunologic reactions might be dependent in part on alterations in 
ICAM-1 induction. We report further evidence that the effect of 
UVR on the immune response is hi phasic, showing that ICAM-1 on 
the surface of cultured human keratinocytes is first suppressed and 
then stimulated by UVR. 
MATERIALS AND METHODS 
Human Keratinocyte Cultures Human neonatal foreskin kera-
tinocytes were harvested after overnight incubation at 4 o C in 
0.025% trypsin (Sigma, St. Louis, MO) and were then _plated by a 
previously described technique (27,28] in MCDB-153 (Clonetics, 
San Diego, CA) containing 0.15 mM calcium and whole bovine 
pituitary extract. The cells were expanded in first passage, frozen in 
aliquots in medium containing 10% DMSO (Sigma), and then re-
placed in second passage for the following experiments. Cells were 
plated at a density of 40,000 cells/mm3 in Lab-Tek culture slides 
(Nunc, Naperville, IL) for immunofluorescence examination and in 
six-well tissue-culture plates (Falcon, Becton-Dickenson, Lincoln 
Park, NJ) for analysis by fluorescence-activated cell sorter (FACS). 
Viability of cells was determined by ethidium bromide/acridine 
orange assay using a previously described technique [29). Immuno-
fluorescent staining using monoclonal antibodies to keratins, to 
Langerhans cells (OKT6 Ortho Pharmaceuticals, Raritan NJ), and 
to melanocytes (S-100 Ortho) verified that these cell cultures were 
100% keratinocytes. 
ltnmunofluorescence Detection of ICAM-1 Cell-surface 
ICAM-1 was assessed by immunofluorescence staining with anti-
ICAM-1 (RR 1/1, provided by Robert Rothlein) using modifica-
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tions of a previously described staining protocol (28,30]. The mouse 
monoclonal antibody RR 1/1 (anti CD54, IgG1) was used as pri-
mary antibody, and a fluoresceinated Fab'2 goat anti-mouse IgG 
(Tago, Burlingame, CA) was used as the secondary antibody. For 
negative controls, a mouse monoclonal anti-herpes simplex glyco-
protein antibody of the same isotype (Cappel, Cochranville, PA) 
was used as the first antibody, with the same second antibody. The 
cells were washed with PBS, incubated with primary antibody 
(1:1000 dilution) for 1 hat 4°C, washed in PBS, acetone fixed, air 
dried, incubated with second antibody (1:50 dilution) overnight at 
4 o C, washed with PBS, and then counterstained with propidium 
iodide. In some experiments, propidium iodide nuclear staining was 
omitted. The cells were then dehydrated, air dried, and mounted in 
paraphenylenediamine mounting medium. Staining for ICAM-1 
and for the negative control HSV-11 were evaluated visually using 
an Olympus BH2 epifluorescent microscope. 
ICAM-1 Detection by FACS Analysis FACS analysis used a 
previously described technique for quantitating cell-surface mole-
cules on keratinocytes with minimal internalization (31], adapted to 
the study of ICAM-1 (32]. Keratinocytes were removed from the 
culture plates by very short-term incubation with trypsin/EDTA 
(0.05 percent Irvine Scientific, Santa Ana, CA) and rapidly im-
mersed in 10% FCS to stop the action of the trypsin. The cells were 
then washed and mixed in 1.0% bovine serum albumin (BSA) in 
0.1% sodium azide at 4 o C for 1 h to block non-specific antibody 
binding. The cells in suspension were then incubated in 200 j.li of 
the primary monoclonal antibodies at 1:1000 dilution at 4 oc for 1 
h, fixed in paraformaldehyde 2% in PBS, washed, and then incu-
bated in 200 ,ul of the fluorescein conjugated goat anti-mouse sec-
ondary antibody (1 :50) at 4 oc overnight. The cells were then resus-
pended in 2% paraformaldehyde and washed, and fluorescence was 
measured using an EPICS V (Coulter Corp., Hialeah, FL) FACS. 
Data was presented and analyzed in a number of ways: as the mean 
channel number (reflecting mean fluorescence on a log scale), as 
percent positive cells (reflecting the percent of cells with fluores-
cence beyond that of the negative control), and as log-mean fluores-
cence (incorporating both the log-fluorescence and the number of 
positive cells at each fluorescence value). The log-mean was gener-
ated by computer program (LogMean, Version 1.03, Denver, CO). 
The log-mean sums the cells at each fluorescence value, weighting 
the result for the log fluorescence value. For statistical analysis, the 
log-mean values were expressed as delta log-mean by subtracting 
the log-mean of the HSV II negative control. In this way, each 
ICAM-1 experiment is internally controlled for non-specific anti-
body binding, which can vary among different keratinocyte cul-
tures. 
Stimulation of Cell Cultures by Immunologic Cytokines 
Immunologic cytokines were added to cultures of human keratino-
cytes for 24 or 48 h before measuring cell-surface ICAM-1. The 
cytokines used, concentrations, and sources are as follows: gamma 
interferon (riFN-y; Genentech, San Bruno, CA), 1-500 U /ml; 
ultrapure interleukin-1 (IL-1 containing both IL-1 alpha and IL-1 
beta; Genzyme Boston, MA), 0.3-10 U /ml; granulocyte 
macrophage -colony-stimulating factor (GM-CSF; Genzyme, 
100-500 U /ml), transforming growth factor beta-1 (TGF-P; Col-
lagen Corporation, Palo Alto, CA), 10-1000 _pM, tumor necrosis 
factor alpha (TNF-a; Genzyme), 0.1-100 ngjml. 
UVR Effects on ICAM-1 Induction Keratinocyte cultures 
were irradiated using a Sol-3 solar simulator (Dermalight 2001 with 
h2 filter (295-400 nm], Munich, FRG), which produces a mixed 
UV A and UVB radiation similar to that produced by natural sun-
light. The UVB (290-320 nm) and UVA (320-400 nm) output of 
these bulbs was measured using an International Light IL1350 ra-
diometer (Newbury Port, MA). The UVB output of the bulbs was 
2.30 m W /cm2 and the UVA output of the bulbs was 28.5 m W /cm2 
at a distance of 6.5 em. 
For irradiation experiments, the medium was removed from the 
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Figure 1. Immunofluorescence staining for ICAM-1 on the surface of human keratinocyres in culture. A shows bright continuous cell-surface staining f~:~ 
ICAM-1 in cdls stimulat<:d for 24 h in culture with IFN-y (20 ~/ml). B shows negative cell-surface staining in standard cultures grown in 0.15 mM calciun}: 
with nuclei ltghtly 11lummated by PPD. \ 
cultures and replaced with a thin film of PBS without pH indicators. 
All cultures were exposed to the same heat effects; the time of 
irradiation was varied by covering and uncovering cultures for ap-
propriate times. 
The effects ofUVR on ICAM-1 were studied using two different 
protocols . In the first protocol, the cells were irradiated, recovered 
with medium, and then incubated for 24, 48, 72, or 96 h before 
analysis by FACS for cell-surface ICAM-1 expression. In the second 
protocol, the same procedure was followed, but gamma interferon 
(20 U jml) was added to the cultures 24 h before ICAM analysis. 
The first protocol measured the effect of UVR on ICAM-1 induc-
tion, and the second measured the effect of UVR on ICAM-1 in-
duced by gamma interferon. 
Statistical Analysis Data from multiple experiments were ana-
lyzed by applying the Student t test as employed in Stat Works 
(Apple Computer, Cupertino, CA) statistical program. 
RESULTS 
Gamma interferon produced significant ICAM-1 expression in cul-
tured keratinocytes within 24 h, as demonstrated by immunofluo-
rescence in Fig 1 and by FACS analysis in Fig 2. The fluorescent 
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Figure 2. FACS analysis of cultured human keratinocytes incubated with 
anti-ICAM-1 (clear) or with anti-HSV II negative control (shaded). Cell 
nun1 ber is shown on the ordinate and the fluorescence (log scale) on the 
abscissa. The upper panel represents cells incubated for 24 h with IFN-y (20 
U f ml) and the lower pa11el shows cells that were not inter~eron-stimulatcd . 
Numerical data for the ICAM-1-posltlveccl ls IS md1cated 1n the upper nght 
hand corner of each panel showing the percentage ofiCAM-1 -positive cells 
with fluorescence greater than the negative control (Pos), the mean channel 
fluorescence (Mean), and the log-mean fluorescence of the ICAM-1 -
stained cells (log mean) . 
staining produces a continuous pattern on the surface of the cultut~ 
cells. The FACS analysis shows that interferon produces a sing!~ 
peak of cells with almost 90% of the cells showing greater fluor~ 
cence than the negative control cells. ' 
The comparable effects of riFN-y, riL-l, GM-CSF, TGF-P an~ 
TNF-a on cell-surface ICAM-1 as measured by FACS analysis ~ 
summarized in Table I. All cytokines were tested across broad con 
centration ranges, with and without added gamma interferon. Bo~ 
IFN-y and TNF-a produced enhancement of ICAM-1 directly 
GM-CSF, TGF-p, and JL-1 did not augment ICAM-1 at 24 h. IL- \ 
produced slight augmentation ofiCAM-1 in the presence of r-IFN\ 
y. The effects of gamma interferon plus TNF-a were more th~ 
additive in the representative experiment shown (see Table II) 
TGF-P did not suppress ICAM-1 induction when added to kerati 1 
nocyte cultures along with suboptimal levels of r-IFN-y. \ 
Figure 3 shows a representative experiment when cultured kerati\ 
nocytes are irradiated with UVA plus UVB, cultured with gamm 
interferon for 24 h, and then analyzed for cell-surface ICAM-1. Th~ 
first panel shows the negative control antibody binding (shaded pr~ 
file) compared to the ICAM-1 binding (clear profile). With 50 an~ 
100 mJ/cm2, substantial decrease in the positive peak is seen with \ 
~hi~t of the clear profile ~oward that of th~ negative control. ~ 
md1cated by the decrease m the percent posaive cells (pos) and h), 
the progressive decrease in size of the peak indicating positive flu<\ 
rescence, the major change is a decrease in the percentage of positiv~ 
cells. 
This result is shown quantitatively in Fig 4 in which the del~ 
log-mean fluorescence at each UVR dose is shown. Each bar repre, 
~en~s t?e mean ± SEM for ~our experiments. Highly sig~ifi~an\ 
mh1b1t1on of I CAM-1 expressiOn was seen at 100 m J j cm2 • V 1abtlit)1 
of irradiated cultures was also analyzed 24 h following UVR usin~ 
the ethidium bromide acridine orange assay [29]. Although increas, 
Table I. Profile of Cytokine Regulation of 
ICAM-1 in Cultured Human Keratinocytes (0.15 mM Ca++) 
As Measured by FACS 
Concemrations Dose for Maxinu( 
Cytokine Tested Peak Response ICAM-ll 
IL-1 0.3-10 V/ml 10 Vfml 4.7 
GM-CSF 100-500 U/ml 100 U/ml 6.0 
TGF-P 10 - 1000 pM 10 pM 5.0 
TN F-a 0.1-100 ng/ml 0.3 ng/ml 95.0 
IFN-y 1-100 U/ml 100 U/ml 120.0 
• JCAM-1 expressed as delta log-mean fluorescence compared to negative conmi 
staining with an irrelevant isotype matched monoclonal antibody to Herpes Simplt~, 
virus I. 
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Table II. Synergistic Effects of Cytokines with Gamma 
Interferon on ICAM-1 Expression in Cultured Human 
Keratinocytes (0.15 mM ca++) As Measured by FACS 
Dose of ICAM-1 with 
Dose of Cytokine ICAM-1 Cytokine Plus 
Cytokine INF-y Added to IFN-y with IFN-)1" IFN-yb 
IL-1 20 U/ ml' 1 U/ml 63 76 
GM-CSF 20 U/ml 100 U/ml 62 85 
TGF-fJ 2 U/ mld 300 pM 20 19 
TN F-a 20 U/ ml 3 ng 85 305' 
• Delta log-mean fluorescence for !CAM-I compared to negative control using an 
irrelevant isotype-matched monoclonal antibody for herpes simplex virus I. 
· 'Maximal delta log-mean fluorescence of ICAM-1 in cells stimulated by cytokine 
plus gamma inteferon. 
' Dose of gamma interferon selected to give ncar-maximal ICAM-1 induction with-
out the severe morphologic changes seen with high-dose gamma interferon. 
J Dose of gamma interferon to fi ve suboptimal stimulation to evaluate possible low-
level inhibitory effects ofTGF-P. 
'Value is greater than the sum of those with TN F-a alone (85} and gamma interferon 
(120, Table I} alone. 
., 
.0 
E 
., 
(.) 
-
24 Hours Posllrradlallon 
~~"~~~--'-~ 
gamma-IFN 20 U/ml NO UVB 
Pos: 88.40 
Mean 152.70 
Log Mean 66. 2 
UVB 10mJ/cm2 
Pos: 89.62 
Mean 151.13 
Log Mean 63.1 
gamma-IFN 20 U/ml UVB 50mJ/cm2 
Pos: 55.39 
Mean 137.85 
Log Mean 33.3 
UVB 100mJ/cm2 
Pos: 26.38 
Mean 141.74 
Log Mean 22.3 
It Log Fluorescence 
Figure 3. A representative FACS analysis experiment showing the effects 
of increasing doses of UVR on ICAM-1 expression by IFN-y stimulated 
cultured human keratinocytes. As in Fig 2, ICAM-1 staining is indicated by 
the unshaded traciug and the negative control (irradiated cultures stained with 
anti-HSV II) for each experimental condition is indicated by a shaded profile. 
Note that increasing UV radiation decreases I CAM-1 expression as noted by 
the log mean, percent positive cells, and mean channel fluorescence. The 
greatest change occurs in the percent of positive cells. 
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Figure 4. Effect of increasing UVB on the ability of IFN-y-stimulated 
cultures to express cell-surface ICAM-1 (delta log-mean fluorescence) 24 h 
after irradiation is shown. Each bar represents the mean ± SEM of four 
experiments. Highly significant inhibition is seen at 100 mJ/cm2 • 
ing UVR induced keratinocyte cell death, the percentage of dead 
cells was less than 30% even at the highest UVR dose and was far 
less than the percentage decrease in ICAM-1 (data not shown). 
The effect ofUVR on ICAM-1 expression as measured by FACS 
in gamma interferon- stimulated keratinocytes is shown in Fig 5. At 
variable times (24, 48, 72, and 96 h) following UVR, ICAM-1 was 
measured. Cells were mixed with IFN-y 24 h before ICAM-1 mea-
surement. The collection of bars at 24 h indicate that UVR at high 
doses inhibits ICAM-1 expression as shown previously in detail in 
Fig 4. However, UVR strongly augments ICAM-1 induction by 
gamma interferon at 48 h with 30 mJ/cm2 UVR and at 48, 72, and 
96 h with 60 and 100 mJ/cm 2 UVR. 
The effect of UVR on ICAM-1 induction without exogenous 
interferon is shown in Fig 6. The black bar on the right shows the 
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Figure 5. Effect of UVR on ICAM-1 expression as measured by FACS in 
IFN-y-stimulated keratinocyte cultures is shown. The delta log-mean fluo-
rescence at various UVR doses and times are shown as the mean ± SEM of 
three separate experiments. The different times shown reflect the total time 
after UVR that ICAM-1 was measured; IFN-y was administered 24 h before 
ICAM-1 analysis. Induction with IFN-y alone is shown at the far left. 
Significant ICAM-1 express ion above that seen with interferon alone was 
seen at 48 h with 30 mJ/cm2 (p < 0.01) and with 60 and 100 mJ/cm2 
(p = 0.001). At 72 or 96 h after radiation doses of UVR greater than 30 
mJ/cm2 produced significant ICAM-1 induction: 60 mJ/cm2 , 72 and 96 h, 
p < 0.001; 100 mJ/cm2, 72 h, p = 0.02; 96 h, p < 0.001. 
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Figure 6. Effect of UVR on ICAM-1 expression as measured by FACS is 
shown in keratinocyte cultures without exogenous cytokine stimulation. 
The level ofiCAM-1 expression in IFN-y (20 U /ml) - treated cells is shown 
on the far right. The bars represent the mean± SEM of three experiments 
showing ICAM-1 fluorescence at increasing UVR exposures incubated for 
24, 48, 72, and 96 h following irradiation. At 48 h and later, all cultures 
showed significant enhancement ofiCAM-1 to levels comparable or greater 
to those produced by IFN-y: 10 mJ/cm2, 48, 72, and 96 h, p < 0.01; 30 
mJ/cm2, 48,72 h, p = 0.01, 96 h, p < 0.001 ; 60 mJ/cm2 , 48 h,p < 0.05, 72 
h, p < 0.01, 96 h, p < 0.001; 100 mJ/cm2 , 48 h, p < 0.001, 72 and 96 h, 
p = 0.01. 
level of induction by IFN-y (20 U /ml) used as a positive control. At 
48 h and later, all levels of UVR showed significant induction of 
ICAM-1, even surpassing the absolute levels produced by IFN-y 
alone. 
DISCUSSION 
We have demonstrated that quantitative FACS analysis can be used 
to compare the induction of ICAM-1 by a variety of cytokines. As 
has been shown using other techniques, gamma interferon and 
TN F-a (26] can induce ICAM-1 expression .. Gamma interferon and 
TNF-a in combination produce synerg1st1c ICAM-1 mduct10n. 
Neither GM-CSF, TGF-/3 nor IL-1 directly induced ICAM-1 , and 
TGF-/3 did not inhibit ICAM-1 induction in cu ltured human kerati-
nocytes . 
Moreover, UVR strongly influences interferon-induced ICAM-1 
expression on human keratinocytes, and. can also directly induce 
JCAM-1 expression. This UVR eff~ct ts btphastc .. Ultravwlet radta-
tion at high doses strongly mhtbtts mter~eron-mduced ICAM-1 
expression when measured 24 h after radtat!On. However, when 
irradiated keratinocytes are allowed to recover for 48 h or longer, 
the ICAM-1 levels induced by gamma interferon are augmented. 
Indeed, UV -irradiated cultures will express very high levels of 
ICAM-1 even without endogenous interferon treatment if the cells 
are all owed to recover for 48 h after radiation. 
T he immediate suppression and delayed stimulation of ICAM-1 
on human keratinocytes by UVR parallels the biphasic effects of 
UVR on CHS reactions. The initial suppression of CHS by UVL is 
re lated to the depletion or alteration of Langerhans cel l populations 
[ 1 ,8], to abnormalities in systemic APC functi?n [3 ,~]. to the release 
of pharmacologic inhibitors of lymphocyte stmmla~10n [33), and to 
the generation of suppressor cells (5 -7]. Follo":"mg local UVR 
there is a recovery of CHS (9, 11] that comctdes w1th the repopula-
tion of the epideri?is by potent APC [ 11 ). We pr?pose that the late 
induction of keratmocyte ICAM-1 by UVR may mfluence cell traf-
ficking to the epidermis, promoting the repopulation of the epi-
dermis by APC and the migration of lymphocytes into the ept-
dermis. 
The attachment ofT and B lymphocytes with APC is greatl y 
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influenced by the association of adhesion-molecule receptor/ligan~ 
pairs, including LFA-1/ICAM-1 [1 4-18]. This contact-dependel:l. 
activation ofT and B lytnphocytes leads to the generation of "rt 
helper cells and cytotoxic T lymphocytes, toT -cell activation in tb~ 
mixed leukocyte reaction, and to antibody production (20,21} 
These contact-dependent, adhesion-molecule- dependent pro ' 
cesses produce the specific humoral and cellular effectors of tissu~ 
damage. 
All major effector cell- dependent mechanisms of immunologj~ 
cytotoxicity depend on adhesion molecules to form or stabilize ef: 
fector/target conjugates. Cytotoxic damage by cytotoxic T lyi'tl.' 
phocytes (CTL) (21], natural killing (NK) [23,34J,lymphokine-ac' 
tivated killing (LAK) (22] , and antibody-dependent cellu1~ 
cytotoxicity (ADCC) [24] all depend on LFA-1/ICAM-1 interac 
tion, and ca1  be signilicantly blocked by antibodies to either LFA_, 
or ICAM-1 [21- 24]. Because ICAM-1 is not constituitively ex 
pressed on keratinocytes in high levels, induction of this molecu\~ 
by cytokines and UVR is likely to be an important factor in control 
ling cytotoxic damage to keratinocytes. As recently described b~ 
Kalish (22]. induction ofkeratinocyte ICAM-1 is a strong promote~ 
of keratinocyte cytotoxicity by activated cellular effectors . 0~ 
course, other adhesion-molecu le receptor/ligand pairs might alsl\ 
be mvolved, mcludmg the LFA-1/ICAM-2 pa1r. However, the in 
ducibility of ICAM-1 by a number of biologically relevant factor' 
lead to the conclusion that control of this molecule probably influ \ 
ences the s usceptibility of keratinocytes to several types of cellula~ 
cytotOXICity. 
Photosensitive subacute cutaneous lupus erythematosus (35,36{ 
and neonatal lupus erythematosus (37 ,38J are highl y associated wit~ 
antibodies to SSA/Ro and/or SSB/La. It has been proposed tha 
UVR promotes binding of these autoantibodies to keratinocytes~ 
inducing the discrete cytotoxic damage seen histologicall y (40- 43]1 
We propose that induction of ICAM-1 on keratinocytes might b~ 
another potential trigger for keratinocyte cytotoxicity in photose11 
sitive lupus. Increased ICAM-1 on keratinocytes cell membran~ 
has been shown to grea tl y increase leukocyte binding, and migh~ 
promote ADCC, LAK, NK, or CTL lysis of keratinocyte targets, 
w~ speculate that the induction of ICAM-1 on human keratin\), 
cytes is one trigger of binding of cytotoxic effectors to keratino, 
cytes, and that subsequent keratinocyte cytotoxicity could thCI\ 
occur in the presence of the appropriate effector activation signal(s). 
In the case of photosensitive lupus, we believe that anti-SSA/R.o 
antibody is one such signa l-activation signal for ADCC, but specific 
CTL, or NK, or LAK activation steps might also be involved. 
Whatever the final effector-ac tivation mechanism, initial ICAM-l 
induction might be a necessary trigger involving UVL. 
It is very important to study the effects of cytokines using con, 
centrations that might be obtained in vivo, and also concentrations 
that might be appropriate in initiation phases of dermatitis. Both 
gamma interferon and TNF-a produce profound changes in kera, 
tinocyte biology at high concentrations, causing cytostasis and pro, 
rooting differentiation (44,45]. In our hands, TNF-a at low con, 
centrations was a strong ICAM-1 inducer, but high concentrations 
caused morphologic alterations in cultures and cytostasis (data not 
shown). In contrast to some contemporary investigations of 
ICAM-1 induction, we used low cytokine levels to show that 
ICAM-1 induction occurs under biologically relevant cytokiu~ 
conditions. 
ICAM-1 induction by keratinocytes is influenced by multipl~ 
immunologic and non-immunologic pathways: gamma interferon 
release by ac tivated T lymphocytes; TNF-a release by monocytes, 
Langerhans cell s, and perhaps keratinocytes; and UVR. Induction 
of ce ll-surface ICAM-1 in keratinocytes by gamma interferon is 
mediated through enhanced transcription of message (46}. Addi. 
tiona\ work is necessary to determine whether UVR acts direct\ · 
through signal transduction systems to induce ICAM- 1 or caus 
the release of factors such as TN F-a from keratinocytes that acr as 
autocrine or paracrine stimulators of ICAM-1 expression. An uu. 
derstanding of the relative biologic importance of different 
ICAM-1 inducers will require careful study using biologically rele-
VO L. 95, NO. 2 AUGUST 1990 
vant doses of cytokines, growth factors, or physica l agents. Future 
experiments will verify w h e the r ICAM-1 induction on keratino-
cytes does influe nce lymphocyte traffickin g to th e epidermis, and 
the susceptibili ty of keratinocytes to immunolog ic cytotoxicity. 
We acktJorvledge the ki11d dot1atio11 of RR 1/ 1 a11tibody to ICAM-1 by Robert 
R oth/ei11 of Boehrillger-lllgelheim, Ridgefield, Co111tectiwt. 
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CONFERENCE ON MOLECULAR AND STRUCTURAL BIOLOGY 
OF HAIR GROWTH 
A Conference on Molecular and Structural Biology of Hair Growth will be held at the 
Crystal Gateway Marriot, Arlington, VA, sponsored by The New York Academy of Sciences. 
Information will be exchanged during this meeting which will use the formats of formal 
lectures, open discussions, posters, and social gatherings. The major topics discussed will in-
clude: the regulation of hair follicle structural protein expression, the themes of the molecular 
structure ofhair,laboratory models for studying hair growth, the mesenchymal components of 
the follicle, hair follicle pigmentation, growth factors and cytokines affecting hair growth, 
hormonal influence on molecular processes of the follicle, and principles of hair follicle induc-
tion and cycle. 
The phenomenon of mammalian cutaneous hair growth serves as a model system for study-
ing the basic biological problems of differentiation and epithelial-mesenchymal interactions. 
The recent application of tools of modern cellular and molecular biology to this system 
prompted the interest in an international meeting of hair biology investigators. Conference 
Chairmen: Dr. K. S. Stenn, Yale University, 333 Cedar Street, New Haven, CT 06510-8058; 
A. G. Messenger, Dept. of Dermatology, Royal Hall~.mshire Hospital, University of Sheffield, 
Sheffield, England; Howard P. Baden, Department of Dermatology, Massachusetts General 
Hospital, Fruit Street, Boston, MA 02114. 
There will be contributed poster sessions in conjunction with this conference. The deadline 
for submission of poster abstracts is September 15, 1990. The entire abstract, including title, 
author(s), and affiliations, must be typed single-spaced and contained within a rectangle that 
measures 511 X 4%". (Abstract form is not necessary.) Abstracts should be sent to Dr. K. S. Stenn 
at the above address. 
